The Long, Winding Road of Immunotherapy Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
Hugh Gannon, PhD, a recipient of the 2013 Anna D. Barker Fellowship in Basic Cancer Research, is studying p53's...